vimarsana.com

Latest Breaking News On - Vardhman health specialties - Page 1 : vimarsana.com

K Law, CAM act on health supply chain platform Aknamed s $35m buy of Vardhman Health - Legally India - Career Intelligence for Lawyers, Law Students

Vardhman Health Specialties is a specialty products provider to hospitals in therapeutic areas of oncology, immunotherapy and virology. As per the statement released, both Aknamed and Vardhman are focused on building a robust hospital focused supply chain in India through the use of technology, data, high-quality infrastructure and scale

Indian cloud-based supply chain platform Aknamed buys pharma distributor Vardhman

Photo by Hiraman/Getty Images Aknamed, a cloud-based healthcare supply chain platform in India, has acquired pharmaceutical products distributor Vardhman Health Specialties. It bought the company for $35 million, according to a report. WHY IT MATTERS In a joint statement, the companies said the combination comes at a time of high demand for medical supplies. [T]he need of the hour is to build a strong healthcare supply chain management in the country, they said. The companies will work towards building a robust hospital-focused supply chain in India , leveraging technology, data, high-quality infrastructure and scale. Besides distribution, Vardhman also develops medical devices, as well as healthcare platforms that run on new technologies, such as artificial intelligence and the internet of things.

Even with govt regulations, CoinDCX is aiming big

Even with govt regulations, CoinDCX is aiming big
yourstory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourstory.com Daily Mail and Mail on Sunday newspapers.

Aknamed buys Vardhman Health Specialties for $40 mn

Aknamed buys Vardhman Health Specialties for $40 mn Updated: Updated: Share Article AAA Bengaluru-based Akna Medical (Aknamed), a tech-enabled supply chain platform for the healthcare sector, has acquired Vardhman Health Specialties (Vardhman), a specialty products provider to hospitals in therapeutic areas of oncology, immunotherapy and virology for $40 million. Over the next two years, Aknamed is expected to invest additional capital to fuel organic and inorganic growth while continuing to invest in people, technology and infrastructure, as per a statement. The combined teams of Aknamed and Vardhman would work towards building a robust hospital supply chain in India, through the use of technology, data, quality infrastructure and scale, said the Aknamed.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.